Yi Wei
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Otorhinolaryngology top 2%
- Sinusitis and nasal conditions
Papers in
- Immunology 13
- Immunotherapy and Immune Responses 7
- T-cell and B-cell Immunology 6
- Immune Cell Function and Interaction 6
-
- Sinusitis and nasal conditions 10
- Co-authors
- Min Ni (6 shared papers)Andrew Murphy (4 shared papers)George D. Yancopoulos (2 shared papers)Christos A. Kyratsous (1 shared paper)Richard Copin (1 shared paper)Alina Baum (1 shared paper)Gurinder S. Atwal (2 shared papers)Stephanie Giordano (1 shared paper)
- Journals
- PLoS ONE (4 papers)Proceedings of the National Academy of Sciences (2 papers)Clinical & Experimental Allergy (2 papers)Annals of Allergy Asthma & Immunology (1 paper)Science (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yi Wei
33 papers receiving 1.6k citations
Yi Wei's Hit Papers
Peers
Comparison fields: 5 of 103
- Infectious Diseases 635
- Otorhinolaryngology 123
- Immunology 320
- Immunology and Allergy 88
- Animal Science and Zoology 100
Countries citing papers authored by Yi Wei
This map shows the geographic impact of Yi Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Wei more than expected).
Fields of papers citing papers by Yi Wei
This network shows the impact of papers produced by Yi Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Wei. The network helps show where Yi Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies Hit paper breakdown → | 2020 | 729 |
| 2 | 2012 | 139 | |
| 3 | 2019 | 138 | |
| 4 | 2016 | 128 | |
| 5 | 2017 | 52 | |
| 6 | 2014 | 50 | |
| 7 | 2005 | 35 | |
| 8 | 2013 | 30 | |
| 9 | 2014 | 28 | |
| 10 | 2016 | 27 | |
| 11 | 2014 | 25 | |
| 12 | 2024 | 24 | |
| 13 | 2015 | 24 | |
| 14 | 2013 | 23 | |
| 15 | 2010 | 21 | |
| 16 | 2018 | 20 | |
| 17 | 2014 | 19 | |
| 18 | CCR7 high expression leads to cetuximab resistance by cross-talking with EGFR pathway in PI3K/AKT signals in colorectal cancer. | 2019 | 19 |
| 19 | 2020 | 19 | |
| 20 | 2024 | 19 |
About Yi Wei
Yi Wei is a scholar working on Immunology, Otorhinolaryngology, Molecular Biology, Pulmonary and Respiratory Medicine and Oncology, having authored 36 papers that have together received 1.6k indexed citations. Recurring topics across this work include Sinusitis and nasal conditions (10 papers), Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (6 papers), Single-cell and spatial transcriptomics (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Infectious Diseases (635 citations), Otorhinolaryngology (123 citations), Immunology (320 citations), Immunology and Allergy (88 citations) and Animal Science and Zoology (100 citations). Yi Wei has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Min Ni, Andrew Murphy, George D. Yancopoulos, Christos A. Kyratsous, Richard Copin, Alina Baum, Gurinder S. Atwal, Stephanie Giordano, Nicole Negron and Neil Stahl. Their work appears in journals such as PLoS ONE, Proceedings of the National Academy of Sciences, Clinical & Experimental Allergy, Annals of Allergy Asthma & Immunology and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.